维普期刊资源整合服务平台（V6.5）

1315篇 您的检索式：作者名="ROSELL R"

选中清除导出查看参考文献查看引证文献引用追踪共66页首页上一页第1页下一页末页 /66 跳转

	题名	作者	年代	出处	被引量
1	完全切除的Ⅰ期,Ⅱ期和ⅢA期非小细胞肺癌术后放疗联合辅助化疗对生存率的影响:国际诺维本辅助治疗组织随机临床试验显示文摘研究背景:1998年术后放疗( post operative radiotherapy, PORT )的meta分析表明术后放疗相关死亡率风险增加21%,术后放疗的作用一直是探讨的热点。PORT对于pN0和pN1患者显示出较差的生存率,而对于Ⅲ期和pN2的患者仅轻微提高生存率。通过对术后放疗研究,辅助放疗的作用地位明显下降,随之出现的其他变化如顺铂的使用增加。	Douillard JY Rosell R de Lena Mario 金冶宁	2009	中国癌症杂志2009，19，3：	33
2	Applications of genomics in NSCLC显示文摘	Rosell R Cobo M Isla D		0，，2：	2
3	BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer显示文摘	Taron M Rosell R Felip E		0，，20：	2
4	Nueleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer显示文摘	ROSELL R TARON M BARNADAS A	2003	Cancer Control2003，10，4：	1
5	Phase Ⅱ randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell luagcancer;a cooperative multinational trial显示文摘	Gatzemeier U Betticher DC	2002	Ann Oncol2002，130，10：	1
6	Phase Ⅲ randomized trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced-non-small-cell-lung cancer:a cooperative multinational trial显示文摘	Gatzemeier U Betticher DC	2002	Annals of Oncology2002，13，：	1
7	BRCA1 mRNA expression levels as an indicator of chemoresistanee in lung cancer显示文摘	Taron M Rosell R	2004	Hum Mol Genet2004，13，20：	1
8	The role of chemotherapy in early non-small cell lung cancer management显示文摘	Rosell R FeliP E Maestre J	2001	Lung Cancer2001，34，13：	1
9	ERCC1 mRNA-based ran- domized phase Ⅲ trial of docetaxel doublets with cisplatin or gemcitabine in stage Ⅳ non-small-cell lung cancer patients显示文摘	Rosell R Cobo M Massuti B	2005	J Clin Oncol2005，23，16：	1
10	Long-term fertilization effects on soil organic matter quality and dynamics under different production systems in semiarid pampean soils显示文摘	Galantini J Rosell R	2006	Soil & Tillage Research2006，87，1：	1
11	Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non small cell lung cancer patients显示文摘	ESTELLWR M MONTSERRAT SC ROSELL R	1999	Cancer Res1999，59，：	1
12	A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer显示文摘	Rosell R Gomez-Codina J Camps C	1994	N Engl J Med1994，330，3：	1
13	Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failure显示文摘	CORTS R PORTOLS M ROSELL-LLETE	2012	Pep-tides2012，33，：	1
14	Nucleotide excision repair psthways involved in cisplatin resistance in non-small-cell lung cancer显示文摘	Rosell R Taron M Barnadas A		0，，：	1
15	Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer显示文摘	Felip E Rosell R Maestre JA	2010	J Clin Oncol2010，28，19：	1
16	Poor prognosis Ewingrs sarcoma and peripheral primitive neuroectodermal tumours (PNET) 显示文摘	Maurel J Rosell R Lorenzo JC	1996	Cancer Treat Rev1996，22，6：	1
17	Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer(EURTAC):a multicentre,open-label,randomised phase 3 trial显示文摘	Rosell R Carcereny E Gervais R	2012	Lancet Oncol2012，13，3：	1
18	Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR expressing advanced non-small-cell lung cancer显示文摘	Rosell R Robinet G Szezesna A	2008	Ann Oncol2008，19，2：	1
19	Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients显示文摘	Rosell R Danenberg KD Alberola V	2004	Clin Cancer Res2004，10，：	1
20	Adjuvant vinorel- bine plus cisplatin versus observation in patients with com- pletely resected stage Ib-IIIa non-small-cell lung cancer (adju- vant navelbine international trialist association ): a randomised controlled trial显示文摘	Douillard JY Rosell R De Lena M	2006	Lancet Oncol2006，7，9：	1

返回顶部每页显示：

共66页首页上一页第1页下一页末页 /66 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示